Victor. Pashkov, et.al., Regulator of G protein signaling (RGS16) inhibits hepatic fatty acid oxidation in a carbohydrate response element-binding protein (ChREBP)-dependent manner., The Journal of biological chemistry, 2011, 286

http://rdf.ncbi.nlm.nih.gov/pubmed/21357625

Victor. Pashkov, et.al., Regulator of G protein signaling (RGS16) inhibits hepatic fatty acid oxidation in a carbohydrate response element-binding protein (ChREBP)-dependent manner., The Journal of biological chemistry, 2011, 286

pubmed

allele

http://purl.org/net/cito/citesAsAuthority

• Tg(APOE-rtTA*M2,tetO-Rgs16)#Tmw
  http://metadb.riken.jp/db/mgi_rdf/MGI:5004809
• Rgs16<tm1Tmw>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5004805

class

http://purl.org/net/cito/citesAsAuthority

• Tg(APOE-rtTA*M2,tetO-Rgs16)#Tmw
  http://metadb.riken.jp/db/mgi_rdf/MGI:5004809
• Rgs16<tm1Tmw>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5004805

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• increased fatty acid oxidation_Rgs16<tm1Tmw>/Rgs16<tm1Tmw>
  http://metadb.riken.jp/0014171I129S4SvJaeSor129X1SvJC57BL6Rgs16tm1TmwRgs16tm1TmwRgs16tm1Tmw
• decreased fatty acid oxidation_Tg(APOE-rtTA*M2,tetO-Rgs16)#Tmw/0
  http://metadb.riken.jp/0014172IC57BL6DBATgAPOErtTAM2tetORgs16Tmw0TgAPOErtTAM2tetORgs16Tmw
• decreased circulating ketone body level_Tg(APOE-rtTA*M2,tetO-Rgs16)#Tmw/0
  http://metadb.riken.jp/0003458IC57BL6DBATgAPOErtTAM2tetORgs16Tmw0TgAPOErtTAM2tetORgs16Tmw
• hepatic steatosis_Tg(APOE-rtTA*M2,tetO-Rgs16)#Tmw/0
  http://metadb.riken.jp/0002628IC57BL6DBATgAPOErtTAM2tetORgs16Tmw0TgAPOErtTAM2tetORgs16Tmw
• increased liver triglyceride level_Gna11<tm1Soff>/Gna11<tm1Soff>
  http://metadb.riken.jp/0009355I129S7SvEvBrdGna11tm1SoffGna11tm1SoffGna11tm1Soff
• increased circulating triglyceride level_Tg(APOE-rtTA*M2,tetO-Rgs16)#Tmw/0
  http://metadb.riken.jp/0001552IC57BL6DBATgAPOErtTAM2tetORgs16Tmw0TgAPOErtTAM2tetORgs16Tmw
• decreased circulating cholesterol level_Tg(APOE-rtTA*M2,tetO-Rgs16)#Tmw/0
  http://metadb.riken.jp/0005179IC57BL6DBATgAPOErtTAM2tetORgs16Tmw0TgAPOErtTAM2tetORgs16Tmw
• increased liver triglyceride level_Tg(APOE-rtTA*M2,tetO-Rgs16)#Tmw/0
  http://metadb.riken.jp/0009355IC57BL6DBATgAPOErtTAM2tetORgs16Tmw0TgAPOErtTAM2tetORgs16Tmw
• increased circulating triglyceride level_Gna11<tm1Soff>/Gna11<tm1Soff>
  http://metadb.riken.jp/0001552I129S7SvEvBrdGna11tm1SoffGna11tm1SoffGna11tm1Soff
• increased circulating ketone body level_Rgs16<tm1Tmw>/Rgs16<tm1Tmw>
  http://metadb.riken.jp/0002575I129S4SvJaeSor129X1SvJC57BL6Rgs16tm1TmwRgs16tm1TmwRgs16tm1Tmw
• hepatic steatosis_Gna11<tm1Soff>/Gna11<tm1Soff>
  http://metadb.riken.jp/0002628I129S7SvEvBrdGna11tm1SoffGna11tm1SoffGna11tm1Soff
• decreased circulating glucose level_Tg(APOE-rtTA*M2,tetO-Rgs16)#Tmw/0
  http://metadb.riken.jp/0005560IC57BL6DBATgAPOErtTAM2tetORgs16Tmw0TgAPOErtTAM2tetORgs16Tmw